According to our understanding, an apoptotic prognostic model of BC patients was identified and verified for the first time in our study, which contains two apoptotic genes (IL3RA and AIFM1) and can be used as an independent prognostic marker for BC patients. This evidence concerns the gene IL3RA and breast cancer.